Working… Menu

Cognitive Behavioral Therapy for Patients With an Early Psychosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01511406
Recruitment Status : Completed
First Posted : January 18, 2012
Last Update Posted : October 23, 2014
Stiftelsen Helse og Rehabilitering
Information provided by (Responsible Party):
Oslo University Hospital

Brief Summary:
The purpose of the present study is to examine whether cognitive behavior therapy will reduce depressive symptoms and increase self-esteem for patients with a first episode psychosis.

Condition or disease Intervention/treatment Phase
Psychosis Schizophrenia Depressive Symptoms Self-esteem Behavioral: cognitive behavioral therapy Phase 2

Detailed Description:

A growing body of evidence supports the use of Cognitive Behavioural Therapy (CBT) for the treatment of schizophrenia. The strength of evidence is especially strong for patients with persistent hallucinations and delusions. As it comes to the effect of CBT for patients with a first episode psychosis the picture is more unclear. The main reason is probably that the CBT interventions to a less extent have been adjusted to fit first episode psychosis patients. The main problems for patients with a first episode psychosis (FEP) is rarely persistent hallucinations and delusions but they struggle with social anxiety, depression, alcohol and drug abuse and low self esteem. Forthcoming studies examining the effect of CBT for patients with a first episode psychosis should aim to have a focus on these symptoms.

The main aim of the present study is to examine whether CBT has any effect on depressive symptoms and self-esteem in patients with a FEP.

The study will include patients with a first episode psychosis with Axis-I DSM IV diagnosis of schizophrenia, schizoaffective disorder, delusional disorder, and psychosis not otherwise specified. To be included in the study the patients should meet the criteria of an affective episode the last year or have a score on Calgary Depression of Schizophrenia Scale above four. Patients are randomly selected to either a treatment group or a control (placebo) group. The aim is to include 30 patients in each group. Patients in the treatment group will receive a manual-based CBT intervention comprising up to 26 sessions during a six months period. The control group will receive treatment as usual (TAU).

The patients are assessed before the entry of the study and after 6 months (end of treatment). Moreover they will be assessed after 9 months of ending therapy.


In this study we hypothesize that

  • patients receiving CBT will have less depressive symptoms than TAU-patients at the and of treatment and at six months follow up
  • CBT-patients will demonstrate a better improvement in their self-esteem than TAU-patients at the end of treatment and at six months follow up.

To our knowledge, no previous studies have examined outcome after CBT treatment with regards to depressive symptoms and self-esteem. Furthermore, this is the first randomized controlled study in Norway of CBT among patients with a FEP.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Does Cognitive Behavioral Therapy Improve Depressive Symptoms and Self-Esteem in Patients With a First Episode Psychosis? A Randomized Controlled Study
Study Start Date : January 2011
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: cognitive behavioral therapy
Cognitive behavioral therapy up to 26 sessions
Behavioral: cognitive behavioral therapy
Patients allocated to the treatment arm will receive up to 26 sessions of cognitive behavioral therapy
Other Name: CBT

Primary Outcome Measures :
  1. Calgary Depression rating Scale for Schizophrenia (CDSS) [ Time Frame: up to nine months after end of intervention ]
    Measure depressive symptoms for patients with a psychosis

Secondary Outcome Measures :
  1. Rosenberg Self Esteem Scale [ Time Frame: up to nine months after end of intervention ]
    Measure the level of self esteem among patients with a psychosis

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Participants are eligible for the study if they are diagnosed with a psychotic disorder or bipolar disorder with psychosis according to DSM-IV (i.e. schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder or psychosis NOS
  • Aged between 18-65 years
  • Are capable of giving a written consent to participate in the study.

Exclusion Criteria:

  • A history of head injury, neurological disorders, developmental disorders, and all episodes of psychosis being judged as substance-induced rather than a primary episode of a psychotic disorder.
  • Being in treatment for more than five years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01511406

Layout table for location information
Oslo University Hospital
Oslo, Norway, 0407
Sponsors and Collaborators
Oslo University Hospital
Stiftelsen Helse og Rehabilitering
Layout table for investigator information
Principal Investigator: Jan I Røssberg, MD, PhD Oslo University Hospital

Layout table for additonal information
Responsible Party: Oslo University Hospital Identifier: NCT01511406     History of Changes
Other Study ID Numbers: CBT2011
First Posted: January 18, 2012    Key Record Dates
Last Update Posted: October 23, 2014
Last Verified: October 2014
Keywords provided by Oslo University Hospital:
Cognitive behavioral therapy
Self esteem
Additional relevant MeSH terms:
Layout table for MeSH terms
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Behavioral Symptoms